Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07120945 · ClinicalTrials.gov registry record · NA

Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)

A NA study of Ovarian Cancer and Endometrial Cancer, sponsored by Medtronic - MITG.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
5
Study locations

NCT07120945 is a NA study of Ovarian Cancer and Endometrial Cancer that is actively recruiting participants, run by Medtronic - MITG. The registered enrollment target is 70 participants, below the 729-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (90% lower). The trial reports 5 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07120945, a NA study of Ovarian Cancer and Endometrial Cancer, is actively recruiting participants, sponsored by Medtronic - MITG.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
5
Study locations

Study Summary

The purpose of this research is to evaluate the safety and performance of the investigational Medtronic Hugo™ Robotic Assisted Surgery (RAS) system when used during hysterectomy procedures, including patients being treated for cancer.

Conditions Studied

Ovarian Cancer Endometrial Cancer Cervical Cancer Endometriosis Uterine Prolapse Precancerous/Nonmalignant Condition Uterine Fibroids (UF) Menstrual Disorders Adenomyosis of Uterus

Interventions

  • DEVICE Robotic Assisted-Surgery (RAS) Hysterectomy

Study Locations (5)

Florida

  • Ascension St. Vincent's Riverside - Jacksonville
  • The University of South Florida - Tampa

North Carolina

  • Duke University - Durham

Pennsylvania

  • Allegheny Health Network - West Penn - Pittsburgh

Washington

  • Swedish Medical Center - Seattle

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2025-08-28
Est. Completion 2031-05
Phase NA

Sponsor

Medtronic - MITG

119 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07120945

The ClinicalTrials.gov registry entry for NCT07120945 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 729-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (90% lower). The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.

The record links to 9 conditions, with Ovarian Cancer appearing as the primary indexed condition, and to 1 intervention - of which Robotic Assisted-Surgery (RAS) Hysterectomy is the first listed.

NCT07120945 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Florida, North Carolina, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT07120945 about?

NCT07120945 is a clinical study titled "Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)". The purpose of this research is to evaluate the safety and performance of the investigational Medtronic Hugo™ Robotic Assisted Surgery (RAS) system when used during hysterectomy procedures, including patients being treated for cancer.

What is the current status of trial NCT07120945?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2025-08-28. Estimated completion is 2031-05.

What conditions does trial NCT07120945 study?

This clinical trial studies the following conditions: Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Endometriosis, Uterine Prolapse.

What interventions are being tested in trial NCT07120945?

The interventions under investigation include: Robotic Assisted-Surgery (RAS) Hysterectomy (DEVICE).

Who is sponsoring clinical trial NCT07120945?

This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07120945 being conducted?

This trial has 5 study locations across Florida, North Carolina, Pennsylvania, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ovarian Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Ovarian Cancer

All registered trials for this condition

Endometrial Cancer

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.